Omada Health (OMDA) vs Starling Oncology (STLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Starling Oncology (STLN) has outperformed Omada Health (OMDA) over the past year, gaining 68.3% versus a loss of 10.3%. Omada Health is the larger company by market cap ($1.27 billion vs $637.8 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OMDA | STLN |
|---|---|---|
| Share price | $20.82 | $6.26 |
| Market cap | $1.27B | $637.77M |
| 1-day change | -0.34% | -2.68% |
| YTD return | +32.38% | +80.62% |
| 1-year return | -10.34% | +68.32% |
| 5-year return | — | -35.38% |
| P/E ratio (TTM) | 86.75 | — |
| Forward P/E | 37.44 | — |
| EPS (TTM) | $0.24 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.92 | $7.13 |
| 52-week low | $10.28 | $2.32 |
| Distance from 52-week high | -22.65% | -12.23% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +36.50% | +43.82% |
| Average volume | 1.38M | 1.54M |
| Shares outstanding | 61.22M | 101.92M |
| Employees | 946 | 641 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STLN has outperformed OMDA by 78.7 percentage points over the past year.
About Omada Health
OMDA stock →Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Health Care · Medical/Nursing Services · 946 employees
About Starling Oncology
STLN stock →Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Health Care · Medical/Nursing Services · 641 employees
OMDA vs STLN FAQ
Which is bigger, Omada Health or Starling Oncology?
Omada Health (OMDA) is larger, with a market capitalization of $1.27B compared with $637.77M for Starling Oncology (STLN).
Which stock has performed better over the past year, OMDA or STLN?
STLN returned +68.32% over the past 12 months, compared with -10.34% for OMDA (price return, excluding dividends). Past performance does not predict future results.
Are Omada Health and Starling Oncology in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.